Inflectis Bioscience
Records under this name other than the patents Inflectis Bioscience holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Inflectis Bioscience
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,682,943 | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,100,020 | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,526,297 | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,084,783 | O-Alkyl-Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Disorders Associated with an Accumulation of Misfolded Proteins Lapsed on the fee record Ended Aug 10, 2025 · High confidence | Lapsed on the fee record | Ended Aug 10, 2025 | High confidence |
| US 10,675,257 | Method of treating cancer with a combination of benzylideneguanidine derivatives and chemotherapeutic agent Lapsed on the fee record Ended Jun 9, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 9, 2024 | From the USPTO record |
| US 10,544,093 | O-Alkyl-Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Disorders Associated an Accumulation of Misfolded Proteins Lapsed on the fee record Ended Jan 28, 2024 · High confidence | Lapsed on the fee record | Ended Jan 28, 2024 | High confidence |